SEC Form 4 · accession 0001171843-17-006489
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Finnerty
Officer — Chief Human Resources Officer
Period of report
Oct 30, 2017
Accepted (ET)
Nov 1, 2017 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 30, 2017 | A | 6,800 | $0.00 | A | 6,800 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $54.09 | Oct 30, 2017 | A | 17,000 | A | — | Oct 30, 2017 | Common Stock | 17,000 | 17,000 | D |
Explanation of responses
- F1The restricted stock awards vest in three equal annual installments beginning October 30, 2018.
- F2The stock options vest in three equal annual installments beginning October 30, 2018.